サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1652018

CRISPR・Cas遺伝子の世界市場：市場規模・シェア・動向、業界分析 (種類別・用途別・エンドユーザー別・地域別)、将来予測 (2025年～2034年)

CRISPR & Cas Genes Market Size, Share, Trends, Industry Analysis Report: By Type, Application, End User, and Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 117 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
CRISPR・Cas遺伝子の世界市場：市場規模・シェア・動向、業界分析 (種類別・用途別・エンドユーザー別・地域別)、将来予測 (2025年～2034年)
出版日: 2025年01月01日
発行: Polaris Market Research
ページ情報: 英文 117 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界のCRISPR・Cas遺伝子の市場規模は2034年までに228億2,000万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

CRISPR・Cas遺伝子市場には、医療、農業、バイオテクノロジーにおける遺伝子編集アプリケーションのためのCRISPR・Cas技術の使用が含まれます。この技術はDNAの正確な改変を可能にし、遺伝子研究、病気治療、作物改良の進歩を可能にします。同市場は、個別化医療、遺伝子治療、農業慣行に革命をもたらす可能性があるため、急成長を遂げています。主な促進要因としては、遺伝子研究への投資の増加、遺伝子治療に対する需要の高まり、より持続可能な農業ソリューションの必要性などが挙げられます。しかし、倫理的な懸念や規制上のハードルが市場拡大に影響を与える可能性があります。

CRISPR・Cas遺伝子市場の需要増加は、遺伝子編集技術の進歩、遺伝子研究投資の増加、医療、農業、バイオテクノロジーにおける用途の拡大に起因します。主な促進要因としては、遺伝性疾患を治療するためのCRISPRベースの療法の可能性、強化された形質を持つ遺伝子組み換え作物に対する需要の高まり、効率的な創薬ツールに対するニーズの高まりなどが挙げられます。CRISPR・Cas遺伝子の市場機会は、個別化医療の開発、希少疾患の遺伝子治療、持続可能な食糧生産のための農業バイオテクノロジーへのCRISPRの統合にあります。主な動向としては、次世代CRISPR技術へのシフト、遺伝子治療の臨床試験の増加、バイオテクノロジー企業と学術機関の研究協力の拡大などが挙げられます。

CRISPR・Cas遺伝子市場：分析概要

製品セグメントが最大の市場シェアを占めており、遺伝子編集研究およびアプリケーション用のCRISPRツール、試薬、キットに対する高い需要が牽引しています。サービス分野は、CRISPR関連研究開発のCRO（医薬品開発業務受託機関）へのアウトソーシングの増加により、最も高い成長を遂げています。

バイオメディカル分野は、遺伝性疾患、がん、個別化医療をターゲットとした遺伝子治療へのCRISPR利用の増加により、市場を独占しています。農業分野は、CRISPR技術が作物形質の強化や食糧安全保障の改善に活用されていることから、最も急速に成長しています。

バイオテクノロジー・製薬企業が最大のシェアを占めており、遺伝子疾患や創薬のためにCRISPRベースの治療に多額の投資を行っています。CROとCDMOのセグメントが最も急成長しているのは、これらの組織がバイオテクノロジー企業の臨床試験や遺伝子編集サービスの推進に重要な役割を果たしているからです。

北米は強力なバイオテクノロジー部門、大規模な研究開発投資、遺伝子編集技術に対する規制当局の支援によって市場を独占しています。アジア太平洋は最も成長率の高い地域であり、中国やインドのような国々でCRISPR技術が急速に採用されています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 分析手法

第4章 CRISPR・Cas遺伝子市場の洞察

  • 市場スナップショット
  • CRISPR・Cas遺伝子の市場力学
    • 促進要因と機会
      • CRISPRベースの治療エンドユーザーの進歩
      • 農業バイオアプリケーションにおけるCRISPRの利用増加
    • 抑制要因と課題
      • 配送の課題
  • PESTLE分析
  • CRISPR・Cas遺伝子市場の動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界のCRISPR・Cas遺伝子市場：種類別

  • 主な分析結果
  • イントロダクション
  • 製品
  • サービス

第6章 世界のCRISPR・Cas遺伝子市場：用途別

  • 主な分析結果
  • イントロダクション
  • バイオメディカル
  • 農業

第7章 世界のCRISPR・Cas遺伝子市場：エンドユーザー別

  • 主な分析結果
  • イントロダクション
  • バイオテクノロジー・製薬企業
  • 学術機関・政府系調査機関
  • CRO・CDMO

第8章 世界のCRISPR・Cas遺伝子市場：地域別

  • 主な分析結果
  • イントロダクション
    • CRISPR・Cas遺伝子市場の評価：地域別 (2020～2034年)
  • 北米
    • 北米：種類別 (2020～2034年)
    • 北米：用途別 (2020～2034年)
    • 北米：エンドユーザー別 (2020～2034年)
    • 米国
    • カナダ
  • 欧州
    • 欧州：種類別 (2020～2034年)
    • 欧州：用途別 (2020～2034年)
    • 欧州：エンドユーザー別 (2020～2034年)
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋：種類別 (2020～2034年)
    • アジア太平洋：用途別 (2020～2034年)
    • アジア太平洋：エンドユーザー別 (2020～2034年)
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ
    • 中東・アフリカ：種類別 (2020～2034年)
    • 中東・アフリカ：用途別 (2020～2034年)
    • 中東・アフリカ：エンドユーザー別 (2020～2034年)
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：種類別 (2020～2034年)
    • ラテンアメリカ：用途別 (2020～2034年)
    • ラテンアメリカ：エンドユーザー別 (2020～2034年)
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第9章 競合情勢

  • 事業拡大・企業買収の分析
    • 事業拡大
    • 企業買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • CRISPR Therapeutics
  • Editas Medicine
  • Intellia Therapeutics
  • Caribou Biosciences
  • Sangamo Therapeutics
  • Agilent Technologies
  • Addgene
  • Thermo Fisher Scientific
  • Illumina
  • Life Technologies
  • Precision Biosciences
  • Beam Therapeutics
  • Cellectis
  • Gene Editing Technologies
  • Horizon Discovery
図表

List of Tables:

  • Table 1 Global CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 2 Global CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 3 Global CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 4 North America: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 5 North America: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 6 North America: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 7 U.S.: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 8 U.S.: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 9 U.S.: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 10 Canada: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 11 Canada: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 12 Canada: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 13 Europe: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 14 Europe: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 15 Europe: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 16 UK: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 17 UK: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 18 UK: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 19 France: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 20 France: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 21 France: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 22 Germany: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 23 Germany: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 24 Germany: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 25 Italy: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 26 Italy: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 27 Italy: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 28 Spain: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 29 Spain: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 30 Spain: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 31 Netherlands: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 32 Netherlands: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 33 Netherlands: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 34 Russia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 35 Russia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 36 Russia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 43 China: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 44 China: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 45 China: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 46 India: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 47 India: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 48 India: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 49 Malaysia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 50 Malaysia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 51 Malaysia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 52 Japan: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 53 Japan: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 54 Japan: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 55 Indonesia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 56 Indonesia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 57 Indonesia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 58 South Korea: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 59 South Korea: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 60 South Korea: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 61 Australia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 62 Australia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 63 Australia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 73 UAE: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 74 UAE: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 75 UAE: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 76 Israel: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 77 Israel: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 78 Israel: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 79 South Africa: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 80 South Africa: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 81 South Africa: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 85 Latin America: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 86 Latin America: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 87 Latin America: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 88 Mexico: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 89 Mexico: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 90 Mexico: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 91 Brazil: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 92 Brazil: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 93 Brazil: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 94 Argentina: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 95 Argentina: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 96 Argentina: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global CRISPR & Cas Genes Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global CRISPR & Cas Genes Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Application
  • Figure 9. Global CRISPR & Cas Genes Market, by Application, 2024 & 2034 (USD Billion)
  • Figure 10. Market by End User
  • Figure 11. Global CRISPR & Cas Genes Market, by End User, 2024 & 2034 (USD Billion)
目次
Product Code: PM1738

The global CRISPR & Cas genes market size is expected to reach USD 22.82 billion by 2034, according to a new study by Polaris Market Research. The report "CRISPR & Cas Genes Market Size, Share, Trends, Industry Analysis Report: By Type (Products and Services), Application (Biomedical and Agricultural), End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The CRISPR & Cas genes market involves the use of CRISPR-Cas technology for gene editing applications in medicine, agriculture, and biotechnology. This technology allows precise modifications to DNA, enabling advancements in genetic research, disease treatment, and crop improvement. The market is experiencing rapid growth due to its potential to revolutionize personalized medicine, gene therapies, and agricultural practices. Key drivers include increasing investment in genetic research, rising demand for gene therapies, and the need for more sustainable agricultural solutions. However, ethical concerns and regulatory hurdles may affect market expansion.

The rising CRISPR & Cas genes market demand is attributed to advancements in gene-editing technologies, increased investments in genetic research, and expanding applications in healthcare, agriculture, and biotechnology. Key drivers include the potential for CRISPR-based therapies to treat genetic disorders, the growing demand for genetically modified crops with enhanced traits, and the rising need for efficient drug discovery tools. CRISPR & Cas genes market opportunities lie in the development of personalized medicine, gene therapies for rare diseases, and CRISPR's integration into agricultural biotechnology for sustainable food production. Major trends include the shift toward next-generation CRISPR technologies, an increase in clinical trials for gene therapies, and expanding research collaborations between biotech firms and academic institutions.

CRISPR & Cas Genes Market Report Highlights

The products segment holds the largest market share, driven by high demand for CRISPR tools, reagents, and kits for gene-editing research and applications. The services segment is experiencing the highest growth, fueled by increasing outsourcing of CRISPR-related research and development to contract research organizations (CROs).

The biomedical segment dominates the market, driven by the increasing use of CRISPR for gene therapies targeting genetic disorders, cancer, and personalized medicine. The agricultural segment is the fastest-growing, as CRISPR technologies are being leveraged to enhance crop traits and improve food security.

Biotechnology & pharmaceutical companies hold the largest share, investing heavily in CRISPR-based therapies for genetic diseases and drug discovery. The CRO and CDMO segment is growing the fastest, as these organizations play a critical role in advancing clinical trials and gene-editing services for biotech firms.

North America dominates the market, driven by a strong biotechnology sector, significant R&D investments, and regulatory support for gene-editing technologies. Asia-Pacific is the highest-growing region, with rapid adoption of CRISPR technologies in countries like China and India, focusing on both healthcare and agricultural applications.

Polaris Market Research has segmented the CRISPR & Cas Genes market report on the basis of type, application, end user, and region:

By Type Outlook (Revenue - USD Billion, 2020-2034)

  • Products
  • Services

By Application Outlook (Revenue - USD Billion, 2020-2034)

  • Biomedical
  • Agricultural

By End User Outlook (Revenue - USD Billion, 2020-2034)

  • Biotechnology & Pharmaceutical Companies
  • Academics & Government Research Institutes
  • Contract Research Organizations (CRO) & CDMOs

By Regional Outlook (Revenue - USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global CRISPR & Cas Genes Market Insights

  • 4.1. CRISPR & Cas Genes Market - Market Snapshot
  • 4.2. CRISPR & Cas Genes Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancements in CRISPR-Based Therapeutic End Users
      • 4.2.1.2. Increasing Use of CRISPR in Agricultural BioApplication
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Delivery challenges
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. CRISPR & Cas Genes Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global CRISPR & Cas Genes Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Product
    • 5.3.1. Global CRISPR & Cas Genes Market, by Product, by Region, 2020-2034 (USD Billion)
  • 5.4. Services
    • 5.4.1. Global CRISPR & Cas Genes Market, by Services, by Region, 2020-2034 (USD Billion)

6. Global CRISPR & Cas Genes Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • 6.3. Biomedical
    • 6.3.1. Global CRISPR & Cas Genes Market, by Biomedical, by Region, 2020-2034 (USD Billion)
  • 6.4. Agricultural
    • 6.4.1. Global CRISPR & Cas Genes Market, by Agricultural, by Region, 2020-2034 (USD Billion)

7. Global CRISPR & Cas Genes Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • 7.3. Biotechnology & Pharmaceutical Companies
    • 7.3.1. Global CRISPR & Cas Genes Market, by Biotechnology & Pharmaceutical Companies, by Region, 2020-2034 (USD Billion)
  • 7.4. Academics & Government Research Institutes
    • 7.4.1. Global CRISPR & Cas Genes Market, by Academics & Government Research Institutes, by Region, 2020-2034 (USD Billion)
  • 7.5. Contract Research Organizations (CRO) & CDMOs
    • 7.5.1. Global CRISPR & Cas Genes Market, by Contract Research Organizations (CRO) & CDMOs, by Region, 2020-2034 (USD Billion)

8. Global CRISPR & Cas Genes Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. CRISPR & Cas Genes Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. CRISPR & Cas Genes Market - North America
    • 8.3.1. North America: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
    • 8.3.3. North America: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.3.4. CRISPR & Cas Genes Market - U.S.
      • 8.3.4.1. U.S.: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.3.5. CRISPR & Cas Genes Market - Canada
      • 8.3.5.1. Canada: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • 8.4. CRISPR & Cas Genes Market - Europe
    • 8.4.1. Europe: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
    • 8.4.3. Europe: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.4.4. CRISPR & Cas Genes Market - UK
      • 8.4.4.1. UK: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.4.5. CRISPR & Cas Genes Market - France
      • 8.4.5.1. France: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.4.5.3. France: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.4.6. CRISPR & Cas Genes Market - Germany
      • 8.4.6.1. Germany: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.4.7. CRISPR & Cas Genes Market - Italy
      • 8.4.7.1. Italy: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.4.8. CRISPR & Cas Genes Market - Spain
      • 8.4.8.1. Spain: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.4.9. CRISPR & Cas Genes Market - Netherlands
      • 8.4.9.1. Netherlands: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.4.10. CRISPR & Cas Genes Market - Russia
      • 8.4.10.1. Russia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.4.11. CRISPR & Cas Genes Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • 8.5. CRISPR & Cas Genes Market - Asia Pacific
    • 8.5.1. Asia Pacific: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.5.4. CRISPR & Cas Genes Market - China
      • 8.5.4.1. China: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.5.4.3. China: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.5.5. CRISPR & Cas Genes Market - India
      • 8.5.5.1. India: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.5.5.3. India: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.5.6. CRISPR & Cas Genes Market - Malaysia
      • 8.5.6.1. Malaysia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.5.7. CRISPR & Cas Genes Market - Japan
      • 8.5.7.1. Japan: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.5.8. CRISPR & Cas Genes Market - Indonesia
      • 8.5.8.1. Indonesia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.5.9. CRISPR & Cas Genes Market - South Korea
      • 8.5.9.1. South Korea: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.5.10. CRISPR & Cas Genes Market - Australia
      • 8.5.10.1. Australia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.5.11. CRISPR & Cas Genes Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • 8.6. CRISPR & Cas Genes Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.6.4. CRISPR & Cas Genes Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.6.5. CRISPR & Cas Genes Market - UAE
      • 8.6.5.1. UAE: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.6.6. CRISPR & Cas Genes Market - Israel
      • 8.6.6.1. Israel: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.6.7. CRISPR & Cas Genes Market - South Africa
      • 8.6.7.1. South Africa: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.6.8. CRISPR & Cas Genes Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • 8.7. CRISPR & Cas Genes Market - Latin America
    • 8.7.1. Latin America: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.7.4. CRISPR & Cas Genes Market - Mexico
      • 8.7.4.1. Mexico: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.7.5. CRISPR & Cas Genes Market - Brazil
      • 8.7.5.1. Brazil: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.7.6. CRISPR & Cas Genes Market - Argentina
      • 8.7.6.1. Argentina: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.7.7. CRISPR & Cas Genes Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. CRISPR Therapeutics
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Editas Medicine
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Intellia Therapeutics
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Caribou Biosciences
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Sangamo Therapeutics
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Agilent Technologies
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Addgene
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Thermo Fisher Scientific
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Illumina
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Life Technologies
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Precision Biosciences
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Beam Therapeutics
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Cellectis
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Gene Editing Technologies
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Horizon Discovery
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development